Blackwell, Oxford, pp 5366 Foyer CH, Halliwell B (1976) The presence of glutathione and glutathione reductase in chloroplasts: a proposed role in ascorbic acid metabolism
Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications
(2018) reported that Fe NPs based on MOL and aqueous extracts of M
Currently, no universally accepted treatment guidelines exist, and management strategies are often symptomatic
Preclinical research has demonstrated protective and healing effects on gastric mucosa, intestinal tissue, and esophageal damage
Accordingly, we also searched for the presence of enzymatic reductant sulfiredoxin (SRX) that can reactivate hyperoxidized PRXs (Fig